atrophy and sexual satisfaction. Postmenopausal atrophic vaginitis
Conditions
Interventions
Intervention 1: Control group: use conjugated estrogen vaginal cream for 8 weeks, so that the first two weeks every night, then twice a week until the end of the study period. Intervention 2: Interven
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: Having a willingness to participated in the study Married and have sexual activity age range of 40-65 years Have literacy to read and write Amenorrhoea has been followed for at least 12 months or 6 months amenorrhoea with FSH> 40. Have normal Pap smear in the past 3 years Clinic diagnosis of vaginal atrophy through a set of criteria including: score 65 or more (based on the VAS visual criteria) of the scale of the most vaginal annoyance symptoms (MBS) and having at least 2 signs of the descriptive evaluation table of vaginal mucus, PH> 5 and VMV=55 (vaginal maturation grade).
Exclusion criteria
Exclusion criteria: Abnormal bleeding vaginal (pink to brown spotting or clear bleeding). have chronic illness such as diabetes, arthritis, cardiovascular disease, active liver disease or gallbladder disease. having vaginal infection allergy to estrogen or flax seed compounds don't suffering of endometrial cancer or breast cancer Endometrial cancer or breast cancer known or suspected . Consumer Products hormonal vaginal or transdermal than 4 weeks prior to the study and use of oral estrogen, uterine progesterone 8 weeks before the study and use of implants progesterone and estrogen injections for 3 months and pellets of estrogen and progesterone injections 6 months prior to the study to be
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Atrophy and sexual satisfaction treatment. Timepoint: Performing the intervention then measuring vaginal atrophy and sexual satisfaction in the fourth and eighth weeks. Method of measurement: Using vaginal maturation index of more than 55 and a vaginal pH of more than 5 and gaining a score of 65 or more from the scale of the most vaginal annoying symptoms and having at least two signs of the symptoms of a descriptive evaluation table of vaginal mucus. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFahimeh shakeri
Mashhad University of Medical Sciences
Outcome results
None listed